NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

血小板減少性疾病:流行病學預測

Thrombocytopenia - Epidemiology Forecast to 2028

出版商 DelveInsight Business Research LLP 商品編碼 535003
出版日期 按訂單生產 內容資訊 英文 50 Pages
商品交期: 2-10個工作天內
價格
血小板減少性疾病:流行病學預測 Thrombocytopenia - Epidemiology Forecast to 2028
出版日期: 按訂單生產內容資訊: 英文 50 Pages
簡介

本報告提供血小板減少性疾病治療藥市場相關調查分析,疾病的背景,主要7個國家 (美國、德國、西班牙、義大利、法國、英國、日本)的流行病學相關的系統性資訊。

第1章 主要考察

第2章 血小板減少性疾病:市場概要

第3章 疾病的背景和概要:血小板減少性疾病

  • 簡介
  • 血小板減少性疾病的原因
  • 病因
  • 病理生理學
  • 病因學
  • 症狀
  • 診斷和治療等

第4章 流行病學和患者族群

  • 主要調查結果
  • 族群與預測參數
  • 主要7個國家的血小板減少性疾病患者族群
  • 各國血小板減少性疾病的流行病學
    • 美國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 英國
    • 日本

第5章 附錄

第6章 DelveInsight的功能

第7章 免責聲明

第8章 關於DelveInsight

目錄
Product Code: DIEI0229

DelveInsight's "Thrombocytopenia - Epidemiology Forecast, 2028" report provides a comprehensive analysis of the Thrombocytopenia epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2028.

Markets Covered

  • United States
  • EU5 (Germany, France, Italy, Spain, and the United Kingdom)
  • Japan

Study Period: 2016-2028

Thrombocytopenia Epidemiology

The epidemiology section covers the historical, current as well as forecasted epidemiology for Thrombocytopenia in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders' views are also taken into account to provide a deep understanding of the Thrombocytopenia outlook. It also includes the explanation of changing trends of epidemiology outlining the Thrombocytopenia scenario.

Thrombocytopenia Epidemiology Segmentation

The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the Thrombocytopenia thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.

Report Scope

  • The report covers detailed overview of Thrombocytopenia explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
  • It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan
  • The Thrombocytopenia Report assesses the disease risk and burden and highlights the unmet needs
  • It also helps to recognize the growth opportunities in the 7MM with respect to the patient population

Key strengths

  • 10 Year Forecast
  • 7MM Coverage
  • Total Cases in Thrombocytopenia

Key assessments

  • Patient Segmentation in Thrombocytopenia
  • Thrombocytopenia Risk & Burden
  • Factors driving growth in a specific Thrombocytopenia patient population

Table of Contents

1. Report Introduction

2. Thrombocytopenia Epidemiology Overview at a Glance

  • 2.1. Patient Share Distribution of Thrombocytopenia in 2016
  • 2.2. Patient Share Distribution of Thrombocytopenia in 2028

3. Disease Background and Overview: Thrombocytopenia

  • 3.1. Introduction
  • 3.2. Symptoms
  • 3.3. Etiology
  • 3.4. Risk Factors
  • 3.5. Pathophysiology
  • 3.6. Diagnosis
  • 3.7. Treatment

4. Epidemiology and Patient Population

  • 4.1. Key Findings
  • 4.2. Total Prevalent/ Incident Patient Population of Thrombocytopenia in 7MM
  • 4.3. Total Prevalent/ Incident Patient Population of Thrombocytopenia in 7MM - By Countries

5. Epidemiology of Thrombocytopenia by Countries

  • 5.1. United States
    • 5.1.1. Assumptions and Rationale
    • 5.1.2. Prevalent/Incident Cases of the Thrombocytopenia
    • 5.1.3. Sub-Type Specific cases of the Thrombocytopenia *
    • 5.1.4. Sex- Specific Cases of the Thrombocytopenia *
    • 5.1.5. Diagnosed Cases of the Thrombocytopenia
  • 5.2. EU5
  • 5.3. Assumptions and Rationale
  • 5.4. Germany
    • 5.4.1. Assumptions and Rationale
    • 5.4.2. Prevalent/Incident Cases of the Thrombocytopenia
    • 5.4.3. Sub-Type Specific cases of the Thrombocytopenia *
    • 5.4.4. Sex- Specific Cases of the Thrombocytopenia *
    • 5.4.5. Diagnosed Cases of the Thrombocytopenia
  • 5.5. France
    • 5.5.1. Assumptions and Rationale
    • 5.5.2. Prevalent/Incident Cases of the Thrombocytopenia
    • 5.5.3. Sub-Type Specific cases of the Thrombocytopenia *
    • 5.5.4. Sex- Specific Cases of the Thrombocytopenia *
    • 5.5.5. Diagnosed Cases of the Thrombocytopenia
  • 5.6. Italy
    • 5.6.1. Assumptions and Rationale
    • 5.6.2. Prevalent/Incident Cases of the Thrombocytopenia
    • 5.6.3. Sub-Type Specific cases of the Thrombocytopenia *
    • 5.6.4. Sex- Specific Cases of the Thrombocytopenia *
    • 5.6.5. Diagnosed Cases of the Thrombocytopenia
  • 5.7. Spain
    • 5.7.1. Assumptions and Rationale
    • 5.7.2. Prevalent/Incident Cases of the Thrombocytopenia
    • 5.7.3. Sub-Type Specific cases of the Thrombocytopenia *
    • 5.7.4. Sex- Specific Cases of the Thrombocytopenia *
    • 5.7.5. Diagnosed Cases of the Thrombocytopenia
  • 5.8. United Kingdom
    • 5.8.1. Assumptions and Rationale
    • 5.8.2. Prevalent/Incident Cases of the Thrombocytopenia
    • 5.8.3. Sub-Type Specific cases of the Thrombocytopenia *
    • 5.8.4. Sex- Specific Cases of the Thrombocytopenia *
    • 5.8.5. Diagnosed Cases of the Thrombocytopenia
  • 5.9. Japan
    • 5.9.1. Assumptions and Rationale
    • 5.9.2. Prevalent/Incident Cases of the Thrombocytopenia
    • 5.9.3. Sub-Type Specific cases of the Thrombocytopenia *
    • 5.9.4. Sex- Specific Cases of the Thrombocytopenia *
    • 5.9.5. Diagnosed Cases of the Thrombocytopenia

6. Unmet Needs of the Thrombocytopenia

7. Appendix

8. Report Methodology

  • 8.1. Sources

9. DelveInsight Capabilities

10. Disclaimer

11. About DelveInsight

Indication Specific

List of Tables

  • Table 1: Total Prevalent/Incident Cases of the Thrombocytopenia in 7MM
  • Table 2: Total Prevalent/Incident Cases of the Thrombocytopenia in 7MM by Countries
  • Table 3: Prevalent/Incident Cases of the Thrombocytopenia in United States (2016-2028)
  • Table 4: Sub-Type Specific cases of the Thrombocytopenia in United States (2016-2028)*
  • Table 5: Sex- Specific Cases of the Thrombocytopenia in United States (2016-2028)*
  • Table 6: Diagnosed Cases of the Thrombocytopenia in United States (2016-2028)
  • Table 7: Prevalent/Incident Cases of the Thrombocytopenia in Germany (2016-2028)
  • Table 8: Sub-Type Specific cases of the Thrombocytopenia in Germany (2016-2028) *
  • Table 9: Sex- Specific Cases of the Thrombocytopenia in Germany (2016-2028) *
  • Table 10: Diagnosed Cases of the Thrombocytopenia in Germany (2016-2028)
  • Table 11: Prevalent/Incident Cases of the Thrombocytopenia in France (2016-2028)
  • Table 12: Sub-Type Specific cases of the Thrombocytopenia in France (2016-2028) *
  • Table 13: Sex- Specific Cases of the Thrombocytopenia in France (2016-2028) *
  • Table 14: Diagnosed Cases of the Thrombocytopenia in France (2016-2028)
  • Table 15: Prevalent/Incident Cases of the Thrombocytopenia in Italy (2016-2028)
  • Table 16: Sub-Type Specific cases of the Thrombocytopenia in Italy (2016-2028) *
  • Table 17: Sex- Specific Cases of the Thrombocytopenia in Italy (2016-2028) *
  • Table 18: Diagnosed Cases of the Thrombocytopenia in Italy (2016-2028)
  • Table 19: Prevalent/Incident Cases of the Thrombocytopenia in Spain (2016-2028)
  • Table 20: Sub-Type Specific cases of the Thrombocytopenia in Spain (2016-2028) *
  • Table 21: Sex- Specific Cases of the Thrombocytopenia in Spain (2016-2028) *
  • Table 22: Diagnosed Cases of the Thrombocytopenia in Spain (2016-2028)
  • Table 23: Prevalent/Incident Cases of the Thrombocytopenia in UK (2016-2028)
  • Table 24: Sub-Type Specific cases of the Thrombocytopenia in UK (2016-2028) *
  • Table 25: Sex- Specific Cases of the Thrombocytopenia in UK (2016-2028) *
  • Table 26: Diagnosed Cases of the Thrombocytopenia in UK (2016-2028)
  • Table 27: Prevalent/Incident Cases of the Thrombocytopenia in Japan (2016-2028)
  • Table 28: Sub-Type Specific cases of the Thrombocytopenia in Japan (2016-2028) *
  • Table 29: Sex- Specific Cases of the Thrombocytopenia in Japan (2016-2028) *
  • Table 30: Diagnosed Cases of the Thrombocytopenia in Japan (2016-2028)

List of Figures

  • Figure 1: Total Prevalent/Incident Cases of the Thrombocytopenia in 7MM
  • Figure 2: Total Prevalent/Incident Cases of the Thrombocytopenia in 7MM by Countries
  • Figure 3: Prevalent/Incident Cases of the Thrombocytopenia in United States (2016-2028)
  • Figure 4: Sub-Type Specific cases of the Thrombocytopenia in United States (2016-2028)*
  • Figure 5: Sex- Specific Cases of the Thrombocytopenia in United States (2016-2028)*
  • Figure 6: Diagnosed Cases of the Thrombocytopenia in United States (2016-2028)
  • Figure 7: Prevalent/Incident Cases of the Thrombocytopenia in Germany (2016-2028)
  • Figure 8: Sub-Type Specific cases of the Thrombocytopenia in Germany (2016-2028) *
  • Figure 9: Sex- Specific Cases of the Thrombocytopenia in Germany (2016-2028) *
  • Figure 10: Diagnosed Cases of the Thrombocytopenia in Germany (2016-2028)
  • Figure 11: Prevalent/Incident Cases of the Thrombocytopenia in France (2016-2028)
  • Figure 12: Sub-Type Specific cases of the Thrombocytopenia in France (2016-2028) *
  • Figure 13: Sex- Specific Cases of the Thrombocytopenia in France (2016-2028) *
  • Figure 14: Diagnosed Cases of the Thrombocytopenia in France (2016-2028)
  • Figure 15: Prevalent/Incident Cases of the Thrombocytopenia in Italy (2016-2028)
  • Figure 16: Sub-Type Specific cases of the Thrombocytopenia in Italy (2016-2028) *
  • Figure 17: Sex- Specific Cases of the Thrombocytopenia in Italy (2016-2028) *
  • Figure 18: Diagnosed Cases of the Thrombocytopenia in Italy (2016-2028)
  • Figure 19: Prevalent/Incident Cases of the Thrombocytopenia in Spain (2016-2028)
  • Figure 20: Sub-Type Specific cases of the Thrombocytopenia in Spain (2016-2028) *
  • Figure 21: Sex- Specific Cases of the Thrombocytopenia in Spain (2016-2028) *
  • Figure 22: Diagnosed Cases of the Thrombocytopenia in Spain (2016-2028)
  • Figure 23: Prevalent/Incident Cases of the Thrombocytopenia in UK (2016-2028)
  • Figure 24: Sub-Type Specific cases of the Thrombocytopenia in UK (2016-2028) *
  • Figure 25: Sex- Specific Cases of the Thrombocytopenia in UK (2016-2028) *
  • Figure 26: Diagnosed Cases of the Thrombocytopenia in UK (2016-2028)
  • Figure 27: Prevalent/Incident Cases of the Thrombocytopenia in Japan (2016-2028)
  • Figure 28: Sub-Type Specific cases of the Thrombocytopenia in Japan (2016-2028) *
  • Figure 29: Sex- Specific Cases of the Thrombocytopenia in Japan (2016-2028) *
  • Figure 30: Diagnosed Cases of the Thrombocytopenia in Japan (2016-2028)